Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.23.3
Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2023
Significant Accounting Policies  
Schedule of dilutive securities excluded from the computation of diluted weighted average shares

As of September 30, 

    

2023

    

2022

Common stock purchase options

196,485

 

381,469

Restricted stock units

11,110

 

Common stock purchase warrants

4,030,989

 

9,000

4,238,584

 

390,469

Schedule of warrant liabilities were measured at fair value on a recurring basis

    

Fair Value Measurements 

as of September 30, 2023

(Level 1)

    

(Level 2)

    

(Level 3)

    

Total

Liabilities

 

  

 

  

 

  

 

  

Warrant liabilities

$

$

$

3,428,601

$

3,428,601

Schedule of assumptions were used in determining the fair value of the warrant liabilities

    

As of September 30, 2023

Remaining contractual term (years)

 

1.3 - 5.3

Common stock price volatility

 

343.8%

Risk-free interest rate

 

4.60% - 5.25%

Expected dividend yield

 

Schedule of change in fair value of the warrant liabilities

Warrant

Liabilities

Balance as of March 31, 2023

$

Fair value of warrants issued

5,669,847

Change in fair value

(1,430,351)

Balance as of June 30, 2023

 

4,239,496

Change in fair value

 

(810,895)

Balance as of September 30, 2023

$

3,428,601